X0306 4 2014-03-20 false 0000064670 MEDTRONIC INC MDT 0001438538 Szyman Catherine M 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 false true false false SrVP & Pres Diabetes Common Stock 2014-03-20 4 M false 14335 34.88 A 35877.299 D Common Stock 2014-03-20 4 M false 644 38.81 A 36521.299 D Common Stock 2014-03-20 4 S false 14979 59.5726 D 21542.299 D Employee Stock Option (right to buy) 34.88 2014-03-20 4 M false 14335 0 D 2012-08-01 2021-08-01 Common Stock 14335 14335 D Employee Stock Option (right to buy) 38.81 2014-03-20 4 M false 644 0 D 2013-07-30 2022-07-30 Common Stock 644 25123 D These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. This balance increased by 325.355 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.23 to $59.73, inclusive. The reporting person undertakes to provide to Medtronic, Inc., any security holder of Medtronic, Inc., or the staff of the Secruities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4. Rhonda L. Ingalsbe, Attorney-in-fact 2014-03-21